Pharma shares gained on Thursday, lifted by reports that the US Administration may exclude generic medicines from proposed new import tariffs . The Nifty pharma index climbed 1.05%, with key stocks recording strong gains.

Market responds to potential tariff relief

Aurobindo Pharma led the rally, rising 4.49% to Rs 1,118.9. Lupin gained 2.59% to Rs 1,955, while Piramal Pharma rose 1.83% to Rs 197.35. Sun Pharma added 1.41% to close at Rs 1,654.60, and Cipla advanced 1.26% to Rs 1,513.4. Laurus Labs, Biocon and Dr Reddy’s Laboratories also ended in the green.

Some counters, however, saw mild profit-taking. Gland Pharma slipped 0.61%, Abbott India fell 0.75%, and Ipca Laboratories eased 0.98%.

Rationale behind US review and industry impact

According to a Wall Street Journal report, th

See Full Page